{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:56:44Z","timestamp":1790272604492,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1097\/md.0000000000007368","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T19:36:46Z","timestamp":1499369806000},"page":"e7368","source":"Crossref","is-referenced-by-count":54,"title":["Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Gao","family":"Yunfeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Weiyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xueyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Yilong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gou","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210309","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R2-28-20210309","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur Urol"},{"key":"R3-28-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11934-010-0103-y","article-title":"The quality-of-life impact of prostate cancer treatments","volume":"11","author":"Singh","year":"2010","journal-title":"Curr Urol Rep"},{"key":"R4-28-20210309","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.eururo.2015.04.023","article-title":"Survivorship and improving quality of life in men with prostate cancer","volume":"68","author":"Bourke","year":"2015","journal-title":"Eur Urol"},{"key":"R5-28-20210309","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"R6-28-20210309","first-page":"1518","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"104","author":"Keating","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R7-28-20210309","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.eururo.2015.10.047","article-title":"Exercise for men with prostate cancer: a systematic review and meta-analysis","volume":"69","author":"Bourke","year":"2016","journal-title":"Eur Urol"},{"key":"R8-28-20210309","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bju.12646","article-title":"Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial","volume":"115","author":"Cormie","year":"2015","journal-title":"BJU Int"},{"key":"R9-28-20210309","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","article-title":"Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial","volume":"28","author":"Galv\u00e3o","year":"2010","journal-title":"J Clin Oncol"},{"key":"R10-28-20210309","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3109\/0284186X.2015.1037008","article-title":"Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy","volume":"54","author":"Nilsen","year":"2015","journal-title":"Acta Oncol"},{"key":"R11-28-20210309","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11764-016-0543-6","article-title":"Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study","volume":"10","author":"Gaskin","year":"2016","journal-title":"J Cancer Surviv"},{"key":"R12-28-20210309","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.eururo.2013.09.041","article-title":"A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR","volume":"65","author":"Galvao","year":"2014","journal-title":"Eur Urol"},{"key":"R13-28-20210309","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10552-015-0694-1","article-title":"Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients","volume":"27","author":"Hvid","year":"2016","journal-title":"Cancer Causes Control"},{"key":"R14-28-20210309","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jgo.2016.02.002","article-title":"Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study","volume":"7","author":"Sajid","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"R15-28-20210309","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2007.15.4963","article-title":"Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer","volume":"27","author":"Segal","year":"2009","journal-title":"J Clin Oncol"},{"key":"R16-28-20210309","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00520-009-0694-3","article-title":"Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention","volume":"18","author":"Culos-Reed","year":"2010","journal-title":"Support Care Cancer"},{"key":"R17-28-20210309","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1249\/MSS.0000000000000265","article-title":"Skeletal response to resistance and impact training in prostate cancer survivors","volume":"46","author":"Winters-Stone","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"R18-28-20210309","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1055-9965.EPI-10-1143","article-title":"Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study","volume":"20","author":"Bourke","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R19-28-20210309","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1123\/japa.21.4.455","article-title":"A randomized trial of aerobic versus resistance exercise in prostate cancer survivors","volume":"21","author":"Santa Mina","year":"2013","journal-title":"J Aging Phys Activity"},{"key":"R20-28-20210309","first-page":"25","article-title":"Inflammation, cardiometabolic markers, and functional changes in men with prostate cancer: A randomized controlled trial of a 12-month exercise program","volume":"127","author":"Hojan","year":"2017","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"R21-28-20210309","first-page":"30108","article-title":"Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial","volume":"S0302-2838","author":"Taaffe","year":"2017","journal-title":"Eur Urol"},{"key":"R22-28-20210309","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1534735415583552","article-title":"Effects of a 15-month supervised exercise program on physical and psychological outcomes in prostate cancer patients following prostatectomy: the prorehab study","volume":"14","author":"Zopf","year":"2017","journal-title":"Integr Cancer Ther"},{"key":"R23-28-20210309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"R24-28-20210309","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol"},{"key":"R25-28-20210309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2008.06.006","article-title":"Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study","volume":"68","author":"van Londen","year":"2008","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"R26-28-20210309","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1249\/01.MSS.0000142662.21767.58","article-title":"American College of Sports Medicine Position Stand: physical activity and bone health","volume":"36","author":"Kohrt","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"R27-28-20210309","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1464-410X.2008.07539.x","article-title":"Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer","volume":"102","author":"Galvao","year":"2008","journal-title":"BJU Int"},{"key":"R28-28-20210309","doi-asserted-by":"crossref","first-page":"e0117344","DOI":"10.1371\/journal.pone.0117344","article-title":"Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"10","author":"Bosco","year":"2015","journal-title":"PloS One"},{"key":"R29-28-20210309","doi-asserted-by":"crossref","first-page":"201.e1","DOI":"10.1016\/j.urolonc.2015.02.004","article-title":"Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance","volume":"33","author":"de Cobelli","year":"2015","journal-title":"Urol Oncol"},{"key":"R30-28-20210309","doi-asserted-by":"crossref","first-page":"18424","DOI":"10.18632\/oncotarget.12906","article-title":"Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance","volume":"8","author":"Ferro","year":"2017","journal-title":"Oncotarget"},{"key":"R31-28-20210309","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/aja.2011.104","article-title":"Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy","volume":"14","author":"Storer","year":"2012","journal-title":"Asian J Androl"},{"key":"R32-28-20210309","doi-asserted-by":"crossref","first-page":"e000056","DOI":"10.1136\/bmjsem-2015-000056","article-title":"Sex differences in the effects of 12 weeks sprint interval training on body fat mass and the rates of fatty acid oxidation and VO2max during exercise","volume":"2","author":"Bagley","year":"2016","journal-title":"BMJ Open Sport Exerc Med"},{"key":"R33-28-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000345160","article-title":"Physical exercise and clinically depressed patients: a systematic review and meta-analysis","volume":"67","author":"Silveira","year":"2013","journal-title":"Neuropsychobiology"},{"key":"R34-28-20210309","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","article-title":"Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values","volume":"104","author":"Wadhwa","year":"2009","journal-title":"BJU Int"},{"key":"R35-28-20210309","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.juro.2010.04.068","article-title":"Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men","volume":"184","author":"Alibhai","year":"2010","journal-title":"J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:53:46Z","timestamp":1620960826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201707070-00028"}},"subtitle":["An update meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":35,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007368","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}